参考文献/References:
[1] 汪静皎,黄丹丹,杨树东,等.分化型早期胃癌中肠母细胞表型的淋巴结转移危险度及其与内镜切除术适应标准的关系[J].临床与实验病理学杂志,2021,37(8):922-926.
[2] Khan K,Rane JK,Cunningham D,et al.Efficacy and cardiotoxic safety profile of raltitrexed in fluoropyrimidines-pretreated or high-risk cardiac patients with gi malignancies:Large single-center experience[J].Clin Colorectal Cancer,2019,18(1):64-71.
[3] Yarema R,Mielko J,Fetsych T,et al.Hyperthermic intraperitoneal chemotherapy(HIPEC)in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer:A retrospective cooperative Central-Eastern European study[J].Cancer Med,2019,8(6):2877-2885.
[4] 李 静,徐有青.内镜黏膜下剥离术与内镜下黏膜切除术治疗早期胃癌的效果及术后出血的影响因素分析[J].中国肿瘤外科杂志,2021,13(4):380-383.
[5] 夫尔多斯?阿马努拉,秦 鹏,马尚智,等.腹腔镜下保留幽门及迷走神经胃切除术在早期胃癌患者的对照研究[J].中华普外科手术学杂志:电子版,2021,15(2):170-173.
[6] 张宇飞,何 亮,徐国栋,等.新辅助化疗后行腹腔镜胃切除术治疗局部晚期胃癌的疗效和安全性分析[J].中华保健医学杂志,2021,23(2):146-149.
[7] 李 斌,黄 蓉,李红霞,等.党黄抗癌汤配合肿瘤细胞减灭术中腹腔热灌注及化疗治疗Ⅳ期上皮性卵巢癌临床研究[J].陕西中医,2019,40(11):1562-1565,1569.
[8] 蔡和平,侯 丽,董 青,等.中医综合外治法治疗晚期恶性肿瘤合并胃痞理论及应用探讨[J].陕西中医,2020,41(6):783-785.
[9] 李 翔,齐 涵,李玉文,等.两种切除术对胃癌病人术后康复及外周血细胞表面PD-L1表达的影响[J].临床外科杂志,2021,29(8):754-756.
[10] 魏 娜,张晓智.盐酸安罗替尼或甲磺酸阿帕替尼治疗晚期实体恶性肿瘤疗效及对患者凝血功能的影响[J].陕西医学杂志,2021,50(7):871-874.
[11] 张晶晶,岳丽娟,王 莹,等.奥拉帕利联合奈达铂腹腔热灌注化疗治疗上皮性卵巢癌疗效观察[J].陕西医学杂志,2021,50(12):1566-1569.
[12] 桑秀波,李晓玉,龚 萍,等.肿瘤细胞减灭术加腹腔热灌注化疗治疗卵巢癌的术后不良事件分析[J].临床肿瘤学杂志,2022,27(2):148-152.
[13] 姜瑞涛,王玉彬,王贵军.洛铂、雷替曲塞在进展期胃癌术后患者腹腔热灌注化疗中的安全性对比观察[J].山东医药,2021,61(9):70-73.
[14] 夏 颖,杨 磊,许 斌,等.雷替曲塞与PF方案同步放疗治疗食管癌的疗效比较[J].浙江临床医学,2021,23(5):710-711,714.
[15] 陈 涛,高 峰,邵建平.雷替曲塞联合奥沙利铂治疗晚期结直肠癌的效果[J].河北医药,2021,43(13):2036-2038.
[16] Brandi A,Yonemura Y,Glehen O,et al.Long term survival in patients with peritoneal meta tasised gastric cancer treated with cytoreductive surgery and HIPEC:A multi-institutional cohort from PSOGI[J].Eur J Surg Oncol,2021,47(1):172-180.
[17] Newhook TE,Agnes A,Blum M,et al.Laparoscopic hyperthermic intraperitoneal chemotherapy is safe for patients with peritoneal metastases from gastric cancer and may lead to gastrectomy[J].Ann Surg Oncol,2019,26(5):1394-1400.
[18] Desiderio J,Chao J,Melstrom L,et al.The 30-year experience:A meta analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer[J].Eur J Cancer,2017,79:1-14.
[19] Bonnot PE,Piessen G,Kepenekian V,et al.Cytoreductive surgery with or without hyperthermic intra peritoneal chemotherapy for gastric cancer with peritoneal metastases(CYTO-CHIP study):A propensity score analysis[J].J Clin Oncol,2019,37(23):2028-2040.
[20] Klaver CEL,Wisselink DD,Punt CJA,et al.Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer(COLOPEC):A multicentre,open-label,randomized trial[J].Lancet Gastroenterol Hepatol,2019,4(10):761-770.